As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Stocks that are in favor and making large moves is a segment of the market that I tweet about on a regular basis.These are also the exact type of stocks that I love to trade and alert to my subscribers in real-time.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Alcobra

  • Thursday's Range: $4.23-$4.67
  • 52-Week Range: $3.15-$9.50
  • Thursday's Volume: 386,000
  • Three-Month Average Volume: 102,629

Alcobra (ADHD) , a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. This stock closed up 6.3% to $4.55 in Thursday's trading session.

From a technical perspective, Alcobra ripped sharply higher on Thursday right off its 50-day moving average of $4.19 a share and counter-trended higher during a sharp market drop with strong upside volume flows. This move pushed this stock into breakout territory, since it closed above some near-term overhead resistance at $4.50 a share. That move is now quickly pushing shares of Alcobra within range of triggering a much bigger breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $4.74 to $4.93 a share with high volume.

Traders should now look for long-biased trades in Alcobra as long as it's trending above its 50-day moving average of $4.19 a share or above more near-term support at $4 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 102,629 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $5.66 to its 200-day moving average of $5.84, or even $6 a share.

Teekay Offshore Partners

  • Thursday's Range: $5.25-$6.13
  • 52-Week Range: $2.30-$24.00
  • Thursday's Volume: 1.23 million
  • Three-Month Average Volume: 1.14 million

Teekay Offshore Partners (TOO) - Get Teekay Offshore Partners L.P. Report  provides marine transportation, oil production, storage, long-distance towing, offshore installation and maintenance, and safety services to the offshore oil industry in the North Sea and Brazil. This stock traded up 3.8% to $6.00 in Thursday's trading session.

From a technical perspective, Teekay Offshore Partners jumped notably higher on Thursday right above some near-term support at $5 a share and back above its 50-day moving average of $5.72 a share with above-average volume. This high-volume counter-trend higher versus the overall market weakness is now quickly pushing shares of Teekay Offshore Partners within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $6.20 to $6.68 a share and then above more key resistance at $7.13 a share with high volume.

Traders should now look for long-biased trades in Teekay Offshore Partners as long as it's trending above Thursday's intraday low of $5.25 a share or above more near-term support at $5 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.14 million shares. If that breakout develops soon, then this stock will set up to re-fill some of its previous gap-down-day zone from last December that started near $8 a share. If that gap gets filled with volume, then this stock can quickly tag $9 to $10 a share.

Dimension Therapeutics

  • Thursday's Range: $6.25-$7.17
  • 52-Week Range: $5.39-$15.55
  • Thursday's Volume: 95,000
  • Three-Month Average Volume: 50,895

Dimension Therapeutics (DMTX) , a gene therapy platform company, focuses on discovering and developing therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. This stock traded up 3.2% to $7.08 in Thursday's trading session.

From a technical perspective, Dimension Therapeutics spiked notably higher on Thursday right off some near-term support at $6 a share with above-average volume. This counter-trend move to the upside versus the overall market weakness pushed this stock back above its 20-day moving average of $7.01 a share. Market players should now look for a continuation move to the upside in the short-term if this stock manages to take out Thursday's intraday high of $7.17 a share with strong upside volume flows.

Traders should now look for long-biased trades in Dimension Therapeutics as long as it's trending above some near-term support around $6.50 a share and then once it sustains a move or close above Thursday's intraday high of $7.17 a share with volume that hits near or above 50,895 shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $7.57 to $8, or even $8.50 a share.

TheStreet Recommends

Square

  • Thursday's Range: $9.24-$9.65
  • 52-Week Range: 8.06-$15.91
  • Thursday's Volume: 3.79 million
  • Three-Month Average Volume: 3.10 million

Square (SQ) - Get Square, Inc. Class A Report  develops and provides payment processing, point-of-sale, financial and marketing services worldwide. This stock traded up 2.1% to $9.60 in Thursday's trading session.

From a technical perspective, Square ripped sharply higher on Thursday and displayed relative strength versus the overall market weakness with strong upside volume flows. This stock recently gapped-down sharply lower from over $13.50 a share to under $10.50 a share with heavy downside volume. Following that move, this stock went on to print a near-term low of $8.63 a share, but since then the stock has started to rebound sharply off that recent low. This rebound higher on Thursday is now quickly pushing shares of Square within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out Thursday's intraday high of $9.65 a share and then once it clears more near-term resistance at $9.99 a share with high volume.

Traders should now look for long-biased trades in Square as long as it's trending above Thursday's intraday low of $9.24 a share or above more near-term support around $9 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 3.10 million shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $10.20 to $10.50, or even its gap-down-day high of $11.19 a share. Any high-volume move above $11.19 will then give this stock a chance to re-fill some of its recent gap-down-day zone that started near $13.50 a share.

Stellar Biotechnologies

  • Thursday's Range: $3.09-$3.25
  • 52-Week Range: $0.80-$10.98
  • Thursday's Volume: 64,000
  • Three-Month Average Volume: 48,303

Stellar Biotechnologies (SBOT) , a biotechnology company, engages in the aquaculture, research and development, manufacture and commercialization of keyhole limpet hemocyanin protein primarily in Europe, the U.S. and Asia. This stock traded up 2.5% to $3.19 in Thursday's trading session.

From a technical perspective, Stellar Biotechnologies spiked modestly higher on Thursday right above some near-term support at $3 a share with above-average volume. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $3.03 to $3 a share. Following that potential bottom, this stock has now started to trend a bit higher and it's beginning to move within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if shares of Stellar Biotechnologies manages to take out some near-term overhead resistance levels at its 20-day moving average of $3.35 a share to more key resistance levels at $3.47 to $3.50 a share with high volume.

Traders should now look for long-biased trades in Stellar Biotechnologies as long as it's trending above those recent double bottom support levels or above more key near-term support at $2.78 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 48,303 shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out is next major overhead resistance levels at $4 to its 50-day moving average of $4.21, or even $4.35 to $4.50 a share.

Amedica

  • Thursday's Range: $1.29-$1.45
  • 52-Week Range: $1.16-$12.59
  • Thursday's Volume: 714,000
  • Three-Month Average Volume: 807,951

Amedicaundefined , a commercial-stage biomaterial company, develops, manufactures and sells a range of medical devices based on its silicon nitride ceramic technology platform in the U.S., Europe and South America. This stock traded up 8.4% to $1.41 in Thursday's trading session.

From a technical perspective, Amedica ripped sharply higher on Thursday right off some near-term support at $1.27 a share with lighter-than-average volume. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $1.28 to $1.27 a share. Shares of Amedica ripped up and displayed relative strength on Thursday versus the overall market weakness, and this stock is now quickly moving within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out Thursday's intraday high of $1.45 a share and then above its 20-day moving average of $1.49 a share with high volume.

Traders should now look for long-biased trades in Amedica as long as it's trending above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 807,951 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $1.63 to $1.67, or even $1.80 to $2.20 a share.

Pacific Ethanol

  • Thursday's Range: $4.28-$4.63
  • 52-Week Range: $2.41-$12.54
  • Thursday's Volume: 664,000
  • Three-Month Average Volume: 720,324

Pacific Ethanol (PEIX) - Get Pacific Ethanol, Inc. Report  produces and markets low-carbon renewable fuels in the U.S. This stock traded up 4.6% to $4.53 in Thursday's trading session.

From a technical perspective, Pacific Ethanol ripped sharply higher on Thursday right above some near-term support at $4.25 a share and back above its 20-day moving average of $4.51 a share with lighter-than-average volume. This relative strength to the upside versus the overall market weakness is now quickly pushing shares of Pacific Ethanol within range of triggering a near-term breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at Thursday's intraday high of $4.63 a share to more resistance at $4.80 a share with high volume.

Traders should now look for long-biased trades in Pacific Ethanol as long as it's trending above some key near-term support levels at $4.25 or at $4.09 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 720,324 shares. If that breakout jumps off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $5 to its 200-day moving average of $5.05, or even $5.22 to $5.65 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.